3,219
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice

, , , , , , , , , , , & show all
Pages 558-568 | Received 30 Nov 2016, Accepted 03 Jan 2017, Published online: 09 Feb 2017

References

  • Bock T, Pakkenberg B, Buschard K. (2003). Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52:1716–22
  • Breitling R, Armengaud P, Amtmann A, Herzyk P. (2004). Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573:83–92
  • Chen L, Nakano K, Kimura S, et al. (2011). Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension. Hypertension 57:343–50
  • Chereddy KK, Vandermeulen G, Preat V. (2016). PLGA based drug delivery systems: promising carriers for wound healing activity. Wound Repair Regen 24:223–36
  • Danhier F, Ansorena E, Silva JM, et al. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505–22
  • den Besten G, Van Eunen K, Groen AK, et al. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325–40
  • Folch J, Lebaron FN. (1956). The isolation from brain tissue of a trypsin-resistant protein fraction containing combined inositol, and its relation to neurokeratin. J Neurochem 1:101–8
  • Freedman DH. (2011). How to fix the obesity crisis. Sci Am 304:40–7
  • Gao Y, Ottaway N, Schriever SC, et al. (2014). Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia 62:17–25
  • Hotamisligil GS. (2010). Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900–17
  • Ishikita A, Matoba T, Ikeda G, et al. (2016). Nanoparticle-mediated delivery of mitochondrial division inhibitor 1 to the myocardium protects the heart from ischemia-reperfusion injury through inhibition of mitochondria outer membrane permeabilization: a new therapeutic modality for acute myocardial infarction. J Am Heart Assoc 5:e003872
  • Kamei A, Watanabe Y, Kondo K, et al. (2013). Influence of a short-term iron-deficient diet on hepatic gene expression profiles in rats. PLoS One 8:e65732
  • Koga J, Matoba T, Egashira K. (2016). Anti-inflammatory nanoparticle for prevention of atherosclerotic vascular diseases. J Atheroscler Thromb 23:757–65
  • Kozuka C, Sunagawa S, Ueda R, et al. (2015a). A novel insulinotropic mechanism of whole grain-derived gamma-oryzanol via the suppression of local dopamine D receptor signalling in mouse islet. Br J Pharmacol 172:4519–34
  • Kozuka C, Sunagawa S, Ueda R, et al. (2015b). Gamma-oryzanol protects pancreatic beta-cells against endoplasmic reticulum stress in male mice. Endocrinology 156:1242–50
  • Kozuka C, Yabiku K, Sunagawa S, et al. (2012). Brown rice and its component, gamma-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice. Diabetes 61:3084–93
  • Kozuka C, Yabiku K, Takayama C, et al. (2013). Natural food science based novel approach toward prevention and treatment of obesity and type 2 diabetes: recent studies on brown rice and γ-oryzanol. Obes Res Clin Pract 7:e165–72
  • Kubo M, Egashira K, Inoue T, et al. (2009). Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium. Arterioscler Thromb Vasc Biol 29:796–801
  • Lerma-Garcia MJ, Herrero-Martinez JM, Simo-Alfonso EF, et al. (2009). Composition, industrial processing and applications of rice bran gamma-oryzanol. Food Chem 115:389–404
  • Ley RE, Backhed F, Turnbaugh P, et al. (2005). Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070–5
  • McClean S, Prosser E, Meehan E, et al. (1998). Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci 6:153–63
  • Miwa H, Yamamoto M. (1987). High-performance liquid chromatographic analysis of serum short-chain fatty acids by direct derivatization. J Chromatogr 421:33–41
  • Moller DE. (2001). New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821–7
  • Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuno MI. (2014). Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 5:190
  • Mozaffarian D, Hao T, Rimm EB, et al. (2011). Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364:2392–404
  • Murphy EF, Cotter PD, Healy S, et al. (2010). Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59:1635–42
  • Navarro SM, Morgan TW, Astete CE, et al. (2016). Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days. Nanomedicine (Lond) 11:1653–69
  • Okada H, Inoue Y, Heya T, et al. (1991). Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharm Res 8:787–91
  • Olokoba AB, Obateru OA, Olokoba LB. (2012). Type 2 diabetes mellitus: a review of current trends. Oman Med J 27:269–73
  • Oyadomari S, Harding HP, Zhang Y, et al. (2008). Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 7:520–32
  • Ozcan U, Cao Q, Yilmaz E, et al. (2004). Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457–61
  • Rosenbaum M, Knight R, Leibel RL. (2015). The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 26:493–501
  • Sahana DK, Mittal G, Bhardwaj V, Kumar MN. (2008). PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 97:1530–42
  • Salvado L, Palomer X, Barroso E, Vazquez-Carrera M. (2015). Targeting endoplasmic reticulum stress in insulin resistance. Trends Endocrinol Metab 26:438–48
  • Satoh H, Oshima K, Suda W, et al. (2013). Bacterial population dynamics in a laboratory activated sludge reactor monitored by pyrosequencing of 16S rRNA. Microbes Environ 28:65–70
  • Saxena V, Sadoqi M, Shao J. (2006). Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm 308:200–4
  • Semete B, Booysen L, Lemmer Y, et al. (2010). In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine 6:662–71
  • Shenderova A, Burke TG, Schwendeman SP. (1999). The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm Res 16:241–8
  • Shimabukuro M, Higa M, Kinjo R, et al. (2014). Effects of the brown rice diet on visceral obesity and endothelial function: the BRAVO study. Br J Nutr 111:310–20
  • Sun Q, Spiegelman D, Van Dam RM, et al. (2010). White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med 170:961–9
  • Takeshita K, Yamasaki T, Akira S, et al. (2004). Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 16:685–95
  • Trabold O, Wagner S, Wicke C, et al. (2003). Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair Regen 11:504–9
  • Turnbaugh PJ, Ley RE, Mahowald MA, et al. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–31
  • Walters WA, Xu Z, Knight R. (2014). Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 588:4223–33
  • Zmuda EJ, Powell CA, Hai T. (2011). A method for murine islet isolation and subcapsular kidney transplantation. J Vis Exp 50:e2096